skip to main content
Idioma:
Refinado por: assunto: Animals remover assunto: Protein Kinase Inhibitors - Pharmacology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
In Vitro and In Vivo Activity of Lucitanib in FGFR1/2 Amplified or Mutated Cancer Models
In Vitro and In Vivo Activity of Lucitanib in FGFR1/2 Amplified or Mutated Cancer Models
Material Type:
Artigo 		Adicionar ao Meu Espaço

In Vitro and In Vivo Activity of Lucitanib in FGFR1/2 Amplified or Mutated Cancer Models

Guffanti, Federica ; Chilà, Rosaria ; Bello, Ezia ; Zucchetti, Massimo ; Zangarini, Monique ; Ceriani, Laura ; Ferrari, Mariella ; Lupi, Monica ; Jacquet-Bescond, Anne ; Burbridge, Mike F ; Pierrat, Marie-Jeanne ; Damia, Giovanna

Neoplasia (New York, N.Y.), 2017-01, Vol.19 (1), p.35-42 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
2
S49076 is a novel kinase inhibitor of MET, AXL, and FGFR with strong preclinical activity alone and in association with bevacizumab
S49076 is a novel kinase inhibitor of MET, AXL, and FGFR with strong preclinical activity alone and in association with bevacizumab
Material Type:
Artigo 		Adicionar ao Meu Espaço

S49076 is a novel kinase inhibitor of MET, AXL, and FGFR with strong preclinical activity alone and in association with bevacizumab

Burbridge, Mike F ; Bossard, Céline J ; Saunier, Carine ; Fejes, Imre ; Bruno, Alain ; Léonce, Stéphane ; Ferry, Gilles ; Da Violante, Georges ; Bouzom, François ; Cattan, Valérie ; Jacquet-Bescond, Anne ; Comoglio, Paolo M ; Lockhart, Brian P ; Boutin, Jean A ; Cordi, Alex ; Ortuno, Jean-Claude ; Pierré, Alain ; Hickman, John A ; Cruzalegui, Francisco H ; Depil, Stéphane

Molecular cancer therapeutics, 2013-09, Vol.12 (9), p.1749-1762 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
3
Targeting DYRK1A/B kinases to modulate p21‐cyclin D1‐p27 signalling and induce anti‐tumour activity in a model of human glioblastoma
Targeting DYRK1A/B kinases to modulate p21‐cyclin D1‐p27 signalling and induce anti‐tumour activity in a model of human glioblastoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Targeting DYRK1A/B kinases to modulate p21‐cyclin D1‐p27 signalling and induce anti‐tumour activity in a model of human glioblastoma

Massey, Andrew J. ; Benwell, Karen ; Burbridge, Mike ; Kotschy, Andras ; Walmsley, David Lee

Journal of cellular and molecular medicine, 2021-11, Vol.25 (22), p.10650-10662 [Periódico revisado por pares]

England: John Wiley & Sons, Inc

Texto completo disponível

Citações Citado por
4
Fragment-Derived Selective Inhibitors of Dual-Specificity Kinases DYRK1A and DYRK1B
Fragment-Derived Selective Inhibitors of Dual-Specificity Kinases DYRK1A and DYRK1B
Material Type:
Artigo 		Adicionar ao Meu Espaço

Fragment-Derived Selective Inhibitors of Dual-Specificity Kinases DYRK1A and DYRK1B

Lee Walmsley, David ; Murray, James B ; Dokurno, Pawel ; Massey, Andrew J ; Benwell, Karen ; Fiumana, Andrea ; Foloppe, Nicolas ; Ray, Stuart ; Smith, Julia ; Surgenor, Allan E ; Edmonds, Thomas ; Demarles, Didier ; Burbridge, Mike ; Cruzalegui, Francisco ; Kotschy, Andras ; Hubbard, Roderick E

Journal of medicinal chemistry, 2021-07, Vol.64 (13), p.8971-8991 [Periódico revisado por pares]

United States: American Chemical Society

Texto completo disponível

Citações Citado por
5
Structure-Guided Discovery of Potent and Selective DYRK1A Inhibitors
Structure-Guided Discovery of Potent and Selective DYRK1A Inhibitors
Material Type:
Artigo 		Adicionar ao Meu Espaço

Structure-Guided Discovery of Potent and Selective DYRK1A Inhibitors

Weber, Csaba ; Sipos, Melinda ; Paczal, Attila ; Balint, Balazs ; Kun, Vilibald ; Foloppe, Nicolas ; Dokurno, Pawel ; Massey, Andrew J ; Walmsley, David Lee ; Hubbard, Roderick E ; Murray, James ; Benwell, Karen ; Edmonds, Thomas ; Demarles, Didier ; Bruno, Alain ; Burbridge, Mike ; Cruzalegui, Francisco ; Kotschy, Andras

Journal of medicinal chemistry, 2021-05, Vol.64 (10), p.6745-6764 [Periódico revisado por pares]

United States: American Chemical Society

Texto completo disponível

Citações Citado por
6
AURKB as a target in non-small cell lung cancer with acquired resistance to anti-EGFR therapy
AURKB as a target in non-small cell lung cancer with acquired resistance to anti-EGFR therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

AURKB as a target in non-small cell lung cancer with acquired resistance to anti-EGFR therapy

Bertran-Alamillo, Jordi ; Cattan, Valérie ; Schoumacher, Marie ; Codony-Servat, Jordi ; Giménez-Capitán, Ana ; Cantero, Frédérique ; Burbridge, Mike ; Rodríguez, Sonia ; Teixidó, Cristina ; Roman, Ruth ; Castellví, Josep ; García-Román, Silvia ; Codony-Servat, Carles ; Viteri, Santiago ; Cardona, Andrés-Felipe ; Karachaliou, Niki ; Rosell, Rafael ; Molina-Vila, Miguel-Angel

Nature communications, 2019-04, Vol.10 (1), p.1812-1812, Article 1812 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.